A5046477372- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Cutaneous Melanoma Detection and Management
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- AI in cancer detection
- Gene expression and cancer classification
- Breast Implant and Reconstruction
- Genetics, Bioinformatics, and Biomedical Research
- Cancer Treatment and Pharmacology
- Cancer Genomics and Diagnostics
Hiroshima University
2022-2025
Hiroshima University Hospital
2024
Axillary staging is commonly performed in patients with clinically node-positive (cN+) breast cancer undergoing neoadjuvant chemotherapy (NACT), regardless of pathological complete response (pCR). Recent evidence has suggested that ypT0 correlates ypN0 and favorable prognosis, potentially supporting the omission axillary such cases. This study aimed to evaluate as a predictive factor for ypN status its prognostic significance cN+ treated NACT. retrospective included 302 NACT at Hiroshima...
Radiofrequency ablation (RFA) is considered a promising alternative to surgical excision for patients with small, unifocal early-stage breast cancer. A significant concern the application of RFA in diagnosed ductal carcinoma situ (DCIS) via needle biopsy underdiagnosis invasive The extent this DCIS eligible has not been clearly defined. This retrospective study assessed lesions as and at our institution from April 2009 March 2024. eligibility criteria included lesion size ≤ 1.5 cm,...
We aimed to investigate the role of dual-phase FDG PET/CT in predicting prognosis patients with operable breast cancer.We retrospectively reviewed data 998 who underwent radical treatment for cancer. Before treatment, scans were performed 1 and 2 h after administration. The maximum standardized uptake value (SUVmax) at both time points (SUVmax1 SUVmax2) primary tumor retention index (RI) calculated. PET recurrence risk (PET-RR) was determined based on SUVmax1 RI, disease-free survival (DFS)...
e13033 Background: Based on the companion diagnostic function of Comprehensive Cancer Genome Profiling (CGP) test in Japan, pembrolizumab is standard treatment for patients with Tumor Mutational Burden (TMB)-high (H) solid tumors. In this report, we attempted to extract predictive factors TMB-H from CGP results. Methods: We carried out a retrospective cohort study 42 malignant breast tumors (excluding circulating tumor DNA blood) who underwent testing between June 1, 2019, and November 30,...
The tumor-infiltrating lymphocytes-ultrasonography score is a calculation system for predicting lymphocyte-predominant breast cancers in surgical specimens. A nomogram based on the was developed to predict pathological complete response cancer treated with neoadjuvant chemotherapy.
<title>Abstract</title> Background Radiofrequency ablation (RFA) is considered a promising alternative to surgical excision for patients with small, unifocal early-stage breast cancer. A significant concern the application of RFA in diagnosed ductal carcinoma situ (DCIS) via needle biopsy underdiagnosis invasive The extent this DCIS eligible has not been clearly defined. Methods This retrospective study assessed lesions as and at our institution from April 2009 March 2024. eligibility...